Koers Medicine Man Technologies, Inc. Other OTC
Aandelen
SHWZ
US58468U1060
Farmaceutische producten
Omzet 2024 * | 174 mln. 160 mln. | Omzet 2025 * | 192 mln. 177 mln. | Marktkapitalisatie | 43,81 mln. 40,34 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 0,25 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,23 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 75,43% |
Recentste transcriptie over Medicine Man Technologies, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 16-01-23 | |
Justin Dye
CHM | Chairman | 52 | 05-06-19 |
Ed Eissenstat
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kathy Vrabeck
BRD | Director/Board Member | 60 | 02/11 |
Jeffrey Cozad
BRD | Director/Board Member | 60 | 15-03-21 |
Marc Rubin
BRD | Director/Board Member | 50 | 28-10-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,06% | 6,26 mld. | |
-15,95% | 4,49 mld. | |
+6,36% | 3,29 mld. | |
-11,34% | 3,12 mld. | |
-3,12% | 2,5 mld. | |
+45,41% | 1,94 mld. | |
-7,74% | 1,68 mld. | |
-0,67% | 1,63 mld. | |
-11,32% | 1,56 mld. |